Clinical Applications of Bacteriophages
12 - Assessment of Phage Susceptibility Testing Reproducibility and Agreement Between Methods
Robin Patel
Mayo Clinic, Rochester, MN, USA
24 - BX211 Phage Therapy Effective in Phase II Trial for S aureus Diabetic Foot Osteomyelitis
Merav Bassan
BiomX, Inc, Gaithersburg, MD, USA
25 - CRISPR-Cas3-Engineered Bacteriophage Cocktail Developed to Broadly Target P aeruginosa Infections
Ashley M. Trama
Locus Biosciences, Inc, Research Triangle Park, NC, USA
26 - Phage Therapy of Patients With CF With Achromobacter xylosoxidans: 3 Case Studies
Anca Segall
San Diego State University, San Diego, CA, USA
Questions and Answers (Part 1)
27 - Phage Cocktails vs Pseudomonas aeruginosa Pulmonary Infection: Delivery Routes and Pharmacokinetics
Nino Mzhavia
Walter Reed Army Institute of Research, Silver Spring, MD, USA
28 - Phages Act as Immune Triggers in the Inflamed Gut but Can Be Rewired
Dwayne R. Roach
San Diego State University, San Diego, CA, USA
29 - Bacterial Receptors but Not Anti-Phage Defense Mechanisms Are Major Determinants of Phage Host Range
Julie Pourtois
Stanford University, Stanford, CA, USA
30 - Optimization of Phage Cocktail Design and Administration by a Genetic Algorithm
Nicholas M. Smith
University at Buffalo, Buffalo, NY, USA
Questions and Answers (Part 2)